UK researchers have launched an early stage trial designed to help assess whether AstraZeneca and MSD’s selumetinib could be effective in combination with dexamethasone as a treatment for leukaemia.
Read More
A clinical trial testing AstraZeneca’s experimental drug AZD1775, an inhibitor of the cell cycle regulating protein WEE1, in patients with head and neck cancer has now launched in the UK.
Read More
Cancer Research UK has committed funding of £190 million over the next five years for its network of 13 UK Centres, which aim to accelerate the pathway for getting cutting edge discoveries from the laboratory to patients.
Read More
MSD, Verastem and Cancer Research UK are to trial a new combination of immunotherapy drugs as potential treatment for mesothelioma, non small cell lung and pancreatic cancers.
Read More
